The data, from the SUMMIT and CREST phase II trial cohorts, suggest that the mechanism of bortezomib-induced thrombocytopenia varies from that of other cytotoxic agents and should be managed ...
Get detailed information on Bortezomib, including pronunciation, uses, dosage guidelines, indications, and instructions on how and when to take it and when to avoid it. The updated prescription ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback